Phase 3 Parkinson Disease trials recruiting now

All Parkinson Disease trials, every phase

Other phases for Parkinson Disease

Phase 3 Parkinson Disease trials

• 18F-DOPA II - PET Imaging Optimization
  NCT04706910 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
  NCT04664634 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · 1 location
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
  NCT06976268 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 22 locations
• Fexofenadine as Adjuvant Therapy in Parkinson Disease
  NCT06785298 · Phase: Phase 2, Phase 3 · Ages: 50 Years to 70 Years · Sex: All (male and female) · 1 location
• [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
  NCT06120049 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 4 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.